News Drug Formulary Safety Net Resources
Drug Formulary Categories and Charges Search HA Drug Formulary Self-financed Drugs Available for Purchase by Patients at HA Pharmacy How we evaluate new drugs Governance Drug Management Committee Drug Advisory Committee Drug Formulary Committee Drug & Therapeutics Committee Drug Selection Committee Expert Panel Medication Safety Committee Samaritan Fund Community Care Fund Drug Education HA Drug Formulary Management Manual Frequently Asked Questions Useful Links
HA Drug Formulary
Version 21.3 – with effect from 31 January 2026
  1. The drugs may either be listed as generic or proprietary names, where appropriate. Brand names listed serve as reference only, they do not necessarily indicate the availability of that particular brand.
  2. Some drugs may appear in more than one category due to different formulations and/or indications.
  3. The "Special" drugs will be prescribed as clinically indicated based on the specified indications.
  4. Based on operational logistics and needs, individual cluster/hospital may only stock part of the drugs listed on the HA Drug Formulary.
Drug classes
Result of:
Respiratory
General Drugs Special Drugs Self-financed Items
with Safety Net		 Self-financed Items
without Safety Net
Respiratory
General Drugs Special Drugs Self-financed Items
with Safety Net		 Self-financed Items
without Safety Net
BRONCHODILATORS
AMINOPHYLLINE ACLIDINIUM
COMBIVENT (OR EQUIV) ACLIDINIUM + FORMOTEROL
IPRATROPIUM GLYCOPYRRONIUM (INH)
SALBUTAMOL INDACATEROL
SALBUTAMOL (INH) INDACATEROL + GLYCOPYRRONIUM
TERBUTALINE OLODATEROL
THEOPHYLLINE SALBUTAMOL (INH)
SALMETEROL
TERBUTALINE (INH)
TIOTROPIUM
TIOTROPIUM + OLODATEROL
UMECLIDINIUM
UMECLIDINIUM + VILANTEROL
CORTICOSTEROIDS
BECLOMETHASONE DIPROPIONATE BREZTRI (OR EQUIV)
BUDESONIDE (INH) BUDESONIDE (INH)
BUDESONIDE + FORMOTEROL
CICLESONIDE
ENERZAIR (OR EQUIV)
FLUTICASONE + SALMETEROL
FLUTICASONE PROPIONATE (INH)
FLUTICASONE + FORMOTEROL
FLUTICASONE + VILANTEROL
INDACATEROL + MOMETASONE
TRELEGY (OR EQUIV)
CROMOGLICATE AND RELATED THERAPY AND LEUKOTRIENE RECEPTOR ANTAGONISTS
MONTELUKAST
ROFLUMILAST
ANTIHISTAMINES, HYPOSENSITISATION AND ALLERGIC EMERGENCIES
ACTIFED (OR EQUIV) C1 ESTERASE INHIBITOR BENRALIZUMAB
ACTIFED COMPOUND (OR EQUIV) CETIRIZINE + PSEUDOEPHEDRINE DUPILUMAB
ADRENALINE FEXOFENADINE MEPOLIZUMAB
CETIRIZINE FEXOFENADINE + PSEUDOEPHEDRINE OMALIZUMAB
CHLORPHENIRAMINE ICATIBANT
CYPROHEPTADINE LORATADINE + PSEUDOEPHEDRINE
DESLORATADINE
DEXCHLORPHENIRAMINE
DIPHENHYDRAMINE
EPINEPHRINE
HYDROXYZINE
LORATADINE
PROMETHAZINE
RESPIRATORY STIMULANTS AND PULMONARY SURFACTANTS
BERACTANT
PORACTANT ALFA
OXYGEN
OXYGEN
MUCOLYTICS
ACETYLCYSTEINE
AMBROXOL
BROMHEXINE
CYCLIDROL
AROMATIC INHALATIONS
BENZOIN COMPOUND TINCTURE
COUGH PREPARATIONS
AMMONIA AND IPECACUANHA
COCILLANA (OR EQUIV)
CODEINE PHOSPHATE
DIPHENHYDRAMINE COMPOUND
PHOLCODINE
PROMETHAZINE COMPOUND
SYSTEMIC NASAL DECONGESTANTS
PSEUDOEPHEDRINE
ANTIFIBROTICS
NINTEDANIB (OFEV)
MISCELLANEOUS (RESPIRATORY SYSTEM)
CAFFEINE
LYSOZYME
TALC STERILE